✦ LIBER ✦

Docetaxel/Capecitabine Shows a Survival Advantage over Docetaxel Monotherapy in Patients with Anthracycline-Pretreated Metastatic Breast Cancer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Capecitabine monotherapy in patients wit

✍ S.-H. Lee; J. Lee; J. Park; S. H. Park; K.-E. Lee; S. I. Lee; E. Nam; J. O. Park 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 106 KB

Phase III Study of Gemcitabine Plus Doce

✍ Seidman, A.D. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 180 KB

A phase II study of weekly docetaxel in

✍ Hugo E. R. Ford; Yoon-Sim Yap; David W. Miles; Andreas Makris; Marcia Hall; Liz 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 311 KB

O-49 A phase III trial of Gemcitabine pl

✍ S. Chan; R. Sharma; G. Romieu; T. Huober; T. Delozier; M. Tubiana-Hulin; A. Schn 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Quality of life audit of 161 anthracycli

✍ Twelves, C.J.; Miles, D.W.; Eggleton, S.P.H.; Burrell, A.; Hall, A. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 111 KB

A multicenter phase II trial of docetaxe

✍ Karachaliou, N.; Ziras, N.; Syrigos, K.; Tryfonidis, K.; Papadimitraki, E.; Kont 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 226 KB